Translational Science 2013

As the biopharma industry faces the challenge of increasing cost of drug development, increasing emphasis is placed on strategies to accelerate clinical development, reduce late-stage attrition and pursue innovation through collaboration. Cambridge Healthtech Institute's Ninth Annual Clinical and Translational Science conference at the 2013 Molecular Med Tri-Con will bring together thought leaders from academia, industry and government to share strategies to accelerate and de-risk clinical development through better and earlier safety and POC models, the use of translational biomarkers and imaging, novel clinical trial design and patient selection, and collaboration.